Moreover, the EPO gene and protein expression were reduced in CKD rats, which was significantly reversed by lowering serum IS with the oral adsorbent AST-120 [46], which decreases its serum levels by adsorbing indole from the gut and promoting its excretion through the feces [47]. This evidence concerns the gene EPO and chronic kidney disease.